Limited value of current shoulder arthroplasty registries in evidence-based shoulder surgery: a review of 7 national registries

Karelse, Anne; Tongel, Alexander Van; Gosens, Taco; Boey, Sara De; Wilde, Lieven F. De; Pouliart, Nicole

doi:10.1080/17434440.2021.2014318

Cited by 2 publications

(6 citation statements)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of failure-related data pertaining to the implant, patient, or surgery are not reported in orthopaedic registries [ 30 ]. A degree of heterogeneity is likely to exist among patients with a primary diagnosis of OA [ 29 ].…”

Section: Resultsmentioning

confidence: 99%

“…Improvement in PRO after RTSA is determined by assessing pre-operative and post-operative follow-up scores. PROMS are not a mandatory outcome in orthopaedic registries [ 30 ].…”

Section: Resultsmentioning

confidence: 99%

“…Depending on the surgeon’s preference and geography, different PROMs are used for shoulder arthroplasty. An evaluation of seven national orthopaedic registries (Australia, the United Kingdom (UK), Denmark, the Netherlands, New Zealand, Norway, and Sweden) indicated that the use of PROMs was inconsistent and reported data was incomplete [ 30 ].…”

Section: Resultsmentioning

confidence: 99%

“…Orthopaedic registries differ in the type of PRO instrument used, as well as the frequency and timing of the follow-up, making comparison difficult [ 30 ].…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturers

Gumbie

Costa

Erb

et al. 2022

Journal of Market Access & Health Policy

View full text Add to dashboard Cite

Purpose The success of reverse total shoulder arthroplasty (RTSA) has expanded its use for a broader range of shoulder indications worldwide. Evidence regarding the relative efficacy and long-term safety of medical technologies used in RTSA is subjected to rigorous assessment. Nonetheless, substantial challenges impede market access for innovative shoulder implant technologies for RTSA in Australia, resulting in delayed patient access. Approach This paper addresses the key challenges associated with generating evidence for the health technology assessments of innovative medical technologies for RTSA that are required for access to the Australian market. The transition to value-based care requires establishing a benchmarking reference that incorporates patient-reported outcome measures (PROMs) and combines revision outcomes with additional clinical outcomes to increase patient cohort sizes. Establishing the benchmark would require agreement on the outcome measures to be collected for each indication, and investment in reporting patient-reported outcomes for RTSA to the national orthopaedic registry. Implications for practice The need for increased flexibility in developing evidence for health technology assessment of RTSA medical technologies is required. Optimised approaches for benchmarking RTSA require extensive stakeholder discussions, including the agreement on evidence requirements and follow-up periods, selection of clinical outcomes, as well as pre-operative and post-operative PROMs as a value assessment.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Improvement in PRO after RTSA is determined by assessing pre-operative and post-operative follow-up scores. PROMS are not a mandatory outcome in orthopaedic registries [ 30 ].…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…Orthopaedic registries differ in the type of PRO instrument used, as well as the frequency and timing of the follow-up, making comparison difficult [ 30 ].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturers

Gumbie

Costa

Erb

et al. 2022

Journal of Market Access & Health Policy

View full text Add to dashboard Cite

show abstract

“… 8 However, there are discrepancies in study designs with heterogenous outcomes measures and there is a need for consistency as we move towards more big data. 14 , 18 …”

mentioning

confidence: 99%

European Society for Surgery of the Shoulder and Elbow (SECEC) rotator cuff tear registry Delphi consensus

Hurley,

Calvo,

Collin

et al. 2024

JSES International

Self Cite

View full text Add to dashboard Cite

Limited value of current shoulder arthroplasty registries in evidence-based shoulder surgery: a review of 7 national registries

Cited by 2 publications

References 83 publications

Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturers

Innovative technologies for reverse total shoulder arthroplasty in Australia: Market access challenges and implications for patients, decision-makers, and manufacturers

European Society for Surgery of the Shoulder and Elbow (SECEC) rotator cuff tear registry Delphi consensus

Contact Info

Product

Resources

About